Literature DB >> 12456345

Human viral cardiomyopathy.

Bernhard Maisch1, Arsen D Ristic, Irene Portig, Sabine Pankuweit.   

Abstract

Viral infection of the heart is relatively common, usually asymptomatic and has a spontaneous and complete resolution. It can, however, in rare cases, lead to substantial cardiac damage, development of viral cardiomyopathy and congestive heart failure. Viral cardiomyopathy is defined as viral persistence in a dilated heart. It may be accompanied by myocardial inflammation and then termed inflammatory viral cardiomyopathy (or viral myocarditis with cardiomegaly). If no inflammation is observed in the biopsy of a dilated heart (<14 lymphocytes and macrophages/mm ) the term viral cardiomyopathy or viral persistence in dilated cardiomyopathy should be applied. The diagnosis of myocarditis and viral cardiomyopathy can be made only by endomyocardial biopsy, implementing the WHO/WHF criteria, and PCR techniques for identification of viral genome. The most frequent cardiotropic viruses detected by endomyocardial biopsy are Parvo B19, enteroviruses, adenoviruses, cytomegalovirus, and less frequently Epstein-Barr virus, and influenza virus.

Entities:  

Mesh:

Year:  2003        PMID: 12456345     DOI: 10.2741/962

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

Review 1.  [Extracardiac causes of right ventricular insufficiency].

Authors:  B Maisch; M Christ
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

2.  Fatal perimyocarditis in a migrant worker to the tropics from an unexpected aetiology: a case report.

Authors:  Azarisman Shah Mohd Shah; Mohd Daud Sulaiman; Noorfaizan Saidin; Oteh Maskon
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

Review 3.  Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations.

Authors:  Chiaki Okuse; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

Review 4.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  Pathogenesis of acute rheumatic fever and rheumatic heart disease: evasive after half a century of clinical, epidemiological, and laboratory investigation.

Authors:  E L Kaplan
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis.

Authors:  Masashi Morita; Gordon Stamp; Peter Robins; Anna Dulic; Ian Rosewell; Geza Hrivnak; Graham Daly; Tomas Lindahl; Deborah E Barnes
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Suspected inflammatory cardiomyopathy. Prevalence of Borrelia burgdorferi in endomyocardial biopsies with positive serological evidence.

Authors:  K Karatolios; B Maisch; S Pankuweit
Journal:  Herz       Date:  2014-06-19       Impact factor: 1.443

9.  Expression of coxsackievirus and adenovirus receptor and its cellular localization in myocardial tissues of dilated cardiomyopathy.

Authors:  Tripta Kaur; Baijayantimala Mishra; Uma Nahar Saikia; Mirnalini Sharma; Ajay Bahl; Radha Kanta Ratho
Journal:  Exp Clin Cardiol       Date:  2012

10.  [Familial predisposition and microbial etiology in dilated cardiomyopathy].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.